BIOPHARMA
By
How Is TrialMatchAI from Bordeaux Bioinformatics Center Revolutionizing Cancer Patient Matching with AI in Clinical Trials?
Key Highlights: The Bordeaux Bioinformatics Center, in collaboration with the EOSC4Cancer initiative, has unveiled TrialMatchAI, an advanced AI-driven…
How Can AI Transform Cancer Treatment? KOLs Insights from University of Maryland School of Medicine
Baltimore, MD — With the rapid advancement of artificial intelligence (AI), predictive medicine is becoming a pivotal part…
AI Meets Genomics: Predictive Oncology’s PEDAL™ Platform Advances Tumor-Specific Drug Discovery
Breakthrough aligns with Regeneron’s genomics strategy, signaling acceleration in precision oncology development PITTSBURGH, May 22, 2025 – Predictive…
How Qubit Pharmaceuticals’ Quantum AI Model FeNNix-Bio1 is Transforming Drug Discovery with Ultra-Precise Molecular Simulations
May 23, 2025 Advancing Molecular Simulation for Faster Drug Development Qubit Pharmaceuticals, in collaboration with Sorbonne University, has…
BioNTech to Launch £1 Billion AI-Powered R&D Hub in the UK Backed by £129M Government Grant
Investment to Accelerate AI Innovation in Oncology, Personalized Medicine, and Drug Development May 21, 2025 Establishing an AI-Centric…
Regeneron, Sanofi & Viz.ai: How Are These Industry Leaders Using AI to Transform COPD Care in 2025?
May 20, 2025 In a bold strategic alliance, Regeneron and Sanofi have teamed up with AI healthcare innovator…
How RevolKa’s $1.7M Series A Extension Fuels AI-Driven Drug Discovery for Rare Diseases?
Sendai, Japan – May 20, 2025 RevolKa Ltd., a fast-growing biotechnology company leveraging AI for protein engineering, has…
Is Quantum AI the Future of RNA Drug Discovery? Eli Lilly Strikes $1B+ Deal With Creyon Bio
Key Highlights: INDIANAPOLIS, IN & SAN DIEGO, CA – In a major signal of the industry’s growing confidence…
Can Eli Lilly and Purdue University reshape pharmaceutical innovation through AI with a $250 million investment?
The initiative will focus on applying artificial intelligence, robotics, and data science to improve every stage of the…
AI-driven ALS therapy: How Eli Lilly is expanding its neurodegeneration pipeline with Alchemab’s antibody
Key highlights AI-powered discovery enters clinical stageEli Lilly and Company has entered into a licensing agreement with Alchemab…
How Are Eli Lilly & BigHat Biosciences Using AI to Redefine Antibody Therapeutics?
Key highlights San Mateo, CA – BigHat Biosciences, a biotechnology company applying machine learning to antibody design and…
Can AstraZeneca’s $2.5B Beijing Bet Mark a New Era of AI-Powered Drug Discovery and Biomanufacturing?
Key Highlights A $2.5B Strategic Move to Strengthen Global R&D Leadership AstraZeneca has announced a $2.5 billion strategic…
Pfizer and Data4Cure Collaborate to Advance AI-Driven Drug Discovery Using Knowledge Graphs and LLMs
March 16, 2025 — Santa Clara, CAAt the 2025 Precision Medicine World Conference (PMWC), experts from Pfizer and…
AION Labs and BioMed X Launch Global 2025 Call: Using Generative AI to Discover Novel Drug Target Combinations
Backed by AstraZeneca, Merck, Pfizer, Teva, AWS, and top venture firms, the initiative seeks global innovators to build…
BullFrog AI and Eleison Pharmaceuticals Collaborate to Optimize Phase 3 Oncology Trial
Gaithersburg, Md – Feb 27 2025 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a leading AI-driven drug development…
Incyte and Genesis Therapeutics Forge AI-Driven Partnership to Advance Small Molecule Drug Discovery
BURLINGAME, California – Feb 20, 2025 Accelerating Innovation with AI-Powered Drug Design Incyte (Nasdaq: INCY) and Genesis Therapeutics…
AI-Powered Insilico Medicine Doses First Patient in Phase I Trial for ISM6331, Pan-TEAD Inhibitor, Targeting Mesothelioma and Solid Tumors
Cambridge, Mass. — Jan 22, 2025 Insilico Medicine, a biotechnology company leveraging generative artificial intelligence (AI) for drug…
Insilico Medicine’s AI Platform Unveils GBP2 and HCK as Promising Targets for Endometriosis Treatment
InSilico Medicine — Jan 15, 2025AI-Driven Research Unveils New Therapeutic Approaches Researchers have leveraged artificial intelligence to discover…
